Steven Quay, the founder and CEO of clin­i­cal-stage biotech Atossa Ther­a­peu­tics, is like­ly to be the next di­rec­tor of NIH’s Na­tion­al In­sti­tute of Al­ler­gy and …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.